SiteMap
Alzheimer
Brain diseases
Research
Tau
APP
Abeta
VCDN group
flag

Aging

ALS

ALS/PDC Guam
AGD
Bri
CBD
DLDH
DM1
Down Syndrome
GSS
FTD
FTDP-17
Huntington
Hallenvorden
IBM
Lewy BD
MSA
NPiD c
Parkinson Dementia Guadeloupe
Parkinson
Dementia  in Parkinson 
Pick
Prion
PSP
PEP
Semantic  Dementia
SSP
  ToD
APPmap

1) APP carboxy terminal fragments (CTF) are cleaved into cytotoxic peptides

2) APP CTF have important physiological roles
They are directed towards the nucleus, driven by Fe65.


In the nucleus, APP-CTFs activate transcription factors, for the activation of genes (that could be trophic factors or Neprilysin).

 


Factors involved in the targetting towards nucleus (Pardossi-Picquartd et al, Neuron, Vol. 46, 541–554, May 19, 2005,)


A loss of APP CTFs is observed in AD. It is well correlated with the progression of tau pathology and Abeta deposition. It could be the cause of AD, since these fragments are most likely, directly or indirectly, survival factors. (Sergeant et al, 2002).
In fact, our hypothesis is that Alzheimer 's disease is a true tauopathy stimulated by the lack of trophic factors (loss of APP-CTFs).

 other molecular aspects


 

Home 8/08/05
Publications
flag
Research
Tau
APP
Abeta
Links 
ApoE
 
catenin
 
NSE
 
Parkin 
Pin1 
Presenilins,
Proteasome
Synuclein
 
 
Ubiquitin